Items where Author is "Mross, Klaus"
Number of items: 8. 11 July 2014Mross, Klaus and Büchert, Martin and Frost, Annette and Medinger, Michael and Stopfer, Peter and Studeny, Matus and Kaiser, Rolf. (2014) Vascular effects, efficacy and safety of nintedanib in patients with advanced, refractory colorectal cancer: a prospective phase I subanalysis. BMC cancer, 14. p. 510. 2010Drevs, Joachim and Medinger, Michael and Mross, Klaus and Fuxius, Stefan and Hennig, Juergen and Buechert, Martin and Thomas, Anne and Unger, Clemens and Chen, Bee-Lian and Lebwohl, David and Laurent, Dirk. (2010) A phase IA, open-label, dose-escalating study of PTK787/ZK 222584 administered orally on a continuous dosing schedule in patients with advanced cancer. Anticancer Research, 30 (6). pp. 2335-2339. Medinger, Michael and Mross, Klaus. (2010) Clinical trials with anti-angiogenic agents in hematological malignancies. Journal of Angiogenesis Research, 2 (1). p. 10. Medinger, Michael and Kleinschmidt, Manuela and Mross, Klaus and Wehmeyer, Barbara and Unger, Clemens and Schaefer, Hans-Eckart and Weber, Renate and Azemar, Marc. (2010) c-kit (CD117) expression in human tumors and its prognostic value: an immunohistochemical analysis. Pathology Oncology Research, 16 (3). pp. 295-301. 2007Steinbild, Simone and Arends, Jann and Medinger, Michael and Häring, Brigitte and Frost, Annette and Drevs, Joachim and Unger, Clemens and Strecker, Ralph and Hennig, Jürgen and Mross, Klaus. (2007) Metronomic antiangiogenic therapy with capecitabine and celecoxib in advanced tumor patients--results of a phase II study. Onkologie, 30 (12). pp. 629-635. Unger, Clemens and Häring, Brigitte and Medinger, Michael and Drevs, Joachim and Steinbild, Simone and Kratz, Felix and Mross, Klaus. (2007) Phase I and pharmacokinetic study of the (6-maleimidocaproyl)hydrazone derivative of doxorubicin. Clinical Cancer Research, 13 (16). pp. 4858-4866. Drevs, Joachim and Siegert, Patrizia and Medinger, Michael and Mross, Klaus and Strecker, Ralph and Zirrgiebel, Ute and Harder, Jan and Blum, Hubert and Robertson, Jane and Jürgensmeier, Juliane M. and Puchalski, Thomas A. and Young, Helen and Saunders, Owain and Unger, Clemens. (2007) Phase I clinical study of AZD2171, an oral vascular endothelial growth factor signaling inhibitor, in patients with advanced solid tumors. Journal of Clinical Oncology, 25 (21). pp. 3045-3054. 2005Mross, Klaus and Drevs, Joachim and Müller, Marianne and Medinger, Michael and Marmé, Dieter and Hennig, Jürgen and Morgan, Bruno and Lebwohl, David and Masson, Eric and Ho, Yu-Yun and Günther, Clemens and Laurent, Dirk and Unger, Clemens. (2005) Phase I clinical and pharmacokinetic study of PTK/ZK, a multiple VEGF receptor inhibitor, in patients with liver metastases from solid tumours. European Journal of Cancer, 41 (9). pp. 1291-1299. |
